Results 161 to 170 of about 171,635 (309)

Portal Hypertension [PDF]

Postgraduate Medical Journal, 1947
openaire   +2 more sources

Portal hypertension [PDF]

Medical Journal Armed Forces India, 2012
openaire   +2 more sources

Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic Study

Portal Hypertension &Cirrhosis, EarlyView.
CN‐TIPS is a nationwide, multicenter prospective registry that will enroll 10,000 adults with portal hypertension undergoing transjugular intrahepatic portosystemic shunt in China, integrating perioperative clinical and hemodynamic metrics with standardized imaging (including computational modeling in a dedicated subcohort) and multi‐omics biospecimens,
Yi Xiang, Yong Lv, Hongwei Zhou, Jianbo Zhao, Meng Niu, Jiacheng Liu, Guangchuan Wang, Qi Zhang, Weizhong Zhou, Beijia Yu, Jun Chi, Guo Han, Jiawei Zhang, Long Gao, Wenjing Liu, Zhang Zhang, Tianyu Liu, Wuhua Guo, He Zhao, Gao‐Jun Teng, Xiaolong Qi   +20 more
wiley   +1 more source

Partial splenic embolization as management of portal hypertension-related hypersplenism in pediatric patients. [PDF]

Front Radiol
Salinas-Castro KJ, Mejia-Quiñones V, Quiceno-Ramirez S, Toro-Gutierrez JS, Botero V, Bustamante-Cristancho LA, Holguín-Holguín AJ.   +6 more
europepmc   +1 more source

Microbubble‐Based Ultrasound Contrast Agents in Contrast‐Enhanced Ultrasonography for Managing Portal Hypertension in Cirrhosis

Portal Hypertension &Cirrhosis, EarlyView.
As the hepatic venous pressure gradient (HVPG) remains the current gold standard for diagnosing portal hypertension in cirrhosis, its clinical application is limited by invasiveness, high cost, and restricted availability. Given the urgent need for noninvasive techniques to dynamically monitor portal vein pressure (PVP), contrast‐enhanced ...
Danping Huang, Zefeng Liu, Lingling Liu, Fen Huang, Wenjuan Wang, Guo Zhang   +5 more
wiley   +1 more source

Spontaneous Bacterial Peritonitis in Prehepatic Portal Hypertension: A Rare Complication. [PDF]

ACG Case Rep J
Mendoza-Rodríguez R, Valverde-López F, López-González E, Cabello-Tapia MJ, Redondo-Cerezo E.   +4 more
europepmc   +1 more source

Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Portal Hypertension &Cirrhosis, EarlyView.
MASLD is the most prevalent chronic liver disease worldwide, yet effective pharmacological treatments remain limited. Hyperuricemia is now recognized as a key driver of hepatic steatosis, inflammation, and fibrosis, with elevated serum uric acid levels independently predicting hepatocellular carcinoma and liver‐related mortality.
Rong Wang, Zhenyu Liu, Jun Lin, Weijing Zhang, Xianzhi Liu, Tong Zhang   +5 more
wiley   +1 more source

Radiomics-Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT Scans. [PDF]

Liver Int
Sin C, Watzenboeck ML, Iofinova E, Balcar L, Semmler G, Scheiner B, Lampichler K, Mandorfer M, Moga L, Rautou PE, Ronot M, Menche J, Reiberger T, Scharitzer M.   +13 more
europepmc   +1 more source

Severe Thrombocytopenia Is Associated With Bleeding in Hepatocellular Carcinoma Patients Receiving Antiangiogenic Therapy

Portal Hypertension &Cirrhosis, EarlyView.
Thrombocytopenia is common in hepatocellular carcinoma and may increase bleeding risk during antiangiogenic therapy, yet the clinically relevant platelet threshold remains uncertain. We found that a baseline platelet count < 50 × 109/L was associated with bleeding; patients below this cutoff had a substantially higher bleeding rate than those with ...
Jun Tie, Zhengcai Liu, Xulong Yuan, Kai Li, Jing Niu, Jiao Xu, Li Xu, Yongquan Shi, Shuqiang Yue   +8 more
wiley   +1 more source

Textbook outcomes after splenectomy in patients with portal hypertension. [PDF]

Sci Rep
Chen L, Lin Z, Li D, Wan Y, Lu W, Wu R, Zhang Y, Du Z.   +7 more
europepmc   +1 more source